Diagnos Laboratorium Utama Tbk. vs Nusatama Berkah Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 308B, 111.5K 24h volume), while Nusatama Berkah Tbk. trades at Rp96 (market cap 261.91B, 83.04M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Nusatama Berkah Tbk. is more actively traded (83.04M versus 111.5K). Which is the better fit depends on your goals.
| DGNS | NTBK | |
|---|---|---|
Market Cap | 308B | 261.91B |
Volume | 111.5K | 83.04M |
Lot | 1.12K | 830.4K |
Turnover | 24.73M | 8.12B |
Average Price | 221.78 | 97.75 |
Value | 24.73M | 8.12B |
Indicative Equilibrium Price | 230 | 97 |
Indicative Equilibrium Volume | 110 | 605.7K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nusatama Berkah Tbk hereinafter called the "Company" was established based on notarial Deed No. 12 dated June 26, 2009 of Kenny Dewi Kaniawati, SH, notary based in Bekasi. The company started its commercial activities in 2009.
Read more on NTBK →